Score Overview
See the full market ranking β
Neuroone Medical Technologies Corp fundamental performance
Between 2020 and 2025, revenue grew from $ 1M to $ 12M and net income went from -$ 13M to -$ 3M. Revenue increased in 3 of those 5 years; net income in 1.
Neuroone Medical Technologies Corp currently holds a 5-year HDB Score of 4.4 out of 10. How the HDB Score is calculated.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-08-12 | $ 1.52 | β |
1 Year2025-08-12 | $ 4.78 | -68.17% |
5 Years2021-08-12 | $ 26.46 | -94.26% |
| Period | Last Price2026-08-12 | 1 Year2025-08-12 | 5 Years2021-08-12 |
|---|---|---|---|
| Price | $ 1.52 | $ 4.78 | $ 26.46 |
| Return | β | -68.17% | -94.26% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
| Year | |||
|---|---|---|---|
| 2026 | $ 9M | -$ 6M | $ 2M |
| 2025 | $ 12M | -$ 3M | $ 6M |
| 2024 | $ 3M | -$ 12M | $ 1M |
| 2023 | $ 1M | -$ 11M | $ 5M |
| 2022 | $ 171.17K | -$ 9M | $ 11M |
| 2021 | $ 178.15K | -$ 9M | $ 6M |
| 2020 | $ 1M | -$ 13M | $ 4M |
| 2019 | $ 0.00 | -$ 6M | $ 260.75K |
| 2018 | $ 0.00 | -$ 6M | $ 13.26K |
| IPO2017 | $ 0.00 | -$ 47.77K | $ 522.22K |
| 2016 | $ 742.00 | -$ 62.86K | -$ 1.84K |
| 2015 | $ 773.00 | -$ 36.24K | $ 205.00 |
| 2014 | $ 1.25K | -$ 30.55K | $ 608.00 |
| 2013 | $ 921.00 | -$ 13.96K | $ 1.12K |
| 2012 | $ 921.00 | -$ 13.96K | |
| 2011 | $ 5.4K | -$ 27.6K | $ 13.85K |
| 2010 | $ 1.17K | -$ 6.04K | $ 9.13K |
| 2009 |
Explore beyond NMTC
You're looking at Neuroone Medical Technologies Corp. Members apply the same fundamental framework across all 3,860 companies we cover.
- Every HDB Score β 1, 5, 10, 20 and 30 years, plus all-time
- Revenue and Net Income Consistency for every period
- Rank all 3,860 companies by any metric, not just three
- Filter by sector and currency, and page through the whole list
- Track your holdings in a portfolio
$99/year $149 founding price
Unlock Holder Dashboard30-day money-back guarantee.
